New hope for endometriosis sufferers: drug trial targets severe pain

NCT ID NCT05101317

First seen Nov 18, 2025 · Last updated Jun 12, 2026 · Updated 34 times

Summary

This study tested an experimental drug called HMI-115 in 142 women with moderate-to-severe endometriosis pain. Over 12 weeks, researchers compared the drug to a placebo to see if it safely reduces pain during periods and pelvic pain. The goal is to find a new treatment option for this chronic condition.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOMETRIOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Instytut Matki i Dziecka

    Warsaw, Masovian Voivodeship, Poland

  • Peking Union Medical College Hospital

    Beijing, Beijing Municipality, 100703, China

  • Physicians' Research Options, LLC- Corner Canyon Clinic

    Draper, Utah, 84020, United States

  • Specjalistyczna Poradnia Ginekologiczna Gabinet Ginekologiczny Dr med. Janusza Tomaszewskiego

    Bialystok, Podlaskie Voivodeship, Poland

  • Tidewater Clinical Research/TPW

    Norfolk, Virginia, 23502, United States

Conditions

Explore the condition pages connected to this study.